Byun JY, Aiyeolemi A, Qdaisat A, Park C. Association between epidermal growth factor receptor-tyrosine kinase inhibitors and venous thromboembolism among older patients with advanced non-small cell lung cancer. Cancer. 2024 Jun 7.

논문보기(doi) :  https://doi.org/10.1002/cncr.35424

Jung HI, Kwon SH, Nam JH, Cho JY, Lee EK. Real-world effectiveness of CDK4/6 inhibitors on patients with HR+/HER2- advanced breast cancer in South Korea, focusing on underrepresented patients. Curr Med Res Opin. 2024 May 9:1-9.

논문보기(doi) :  https://doi.org/10.1080/03007995.2024.2349741

Shim YB, Oh BC, Lee EK, Park MH. Comparison of partitioned survival modeling with state transition modeling approaches with or without consideration of brain metastasis: a case study of Osimertinib versus pemetrexed-platinum. BMC Cancer. 2024 Feb 9;24(1):189.

논문보기(doi) :  https://doi.org/10.1186/s12885-024-11971-x

Cho JY, Jang SC, Kang DW, Lee EK, Koh H, Yoon DH, Park MH. A nationwide analysis of the treatment patterns, survival, and medical costs in Korean patients with relapsed or refractory diffuse large B-cell lymphoma. Front Oncol. 2024 Feb 1;14:1282323.

논문보기(doi) : https://doi.org/10.3389/fonc.2024.1282323

Min S, Kwon SH, Lee EK, Nam JH. Cost-effectiveness of improving patients' adherence to tuberculosis treatment in South Korea using discrete event simulation. J Infect Public Health. 2024 Mar;17(3):478-485

논문보기(doi) : https://doi.org/10.1016/j.jiph.2024.01.002